Event Details Development of Stable, Orally Bioavailable, Small-Molecule Positive Modulators of HGF/MET Signaling for the Treatment of Cognitive Impairment July 31, 2022 Supporting Materials Development of Stable, Orally Bioavailable, Small-Molecule Positive Modulators of HGF/MET Signaling for the Treatment of Cognitive Impairment 2.3 MB < SIGN UP FOR EMAIL ALERTS CONTACT IR
Development of Stable, Orally Bioavailable, Small-Molecule Positive Modulators of HGF/MET Signaling for the Treatment of Cognitive Impairment July 31, 2022 Supporting Materials Development of Stable, Orally Bioavailable, Small-Molecule Positive Modulators of HGF/MET Signaling for the Treatment of Cognitive Impairment 2.3 MB
Development of Stable, Orally Bioavailable, Small-Molecule Positive Modulators of HGF/MET Signaling for the Treatment of Cognitive Impairment 2.3 MB